Title | Viral infections and chronic rhinosinusitis. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Volpe S, Irish J, Palumbo S, Lee E, Herbert J, Ramadan I, Chang EH |
Journal | J Allergy Clin Immunol |
Volume | 152 |
Issue | 4 |
Pagination | 819-826 |
Date Published | 2023 Oct |
ISSN | 1097-6825 |
Abstract | Viral infections are the most common cause of upper respiratory infections; they frequently infect adults once or twice and children 6 to 8 times annually. In most cases, these infections are self-limiting and resolve. However, many patients with chronic rhinosinusitis (CRS) relay that their initiating event began with an upper respiratory infection that progressed in both symptom severity and duration. Viruses bind to sinonasal epithelia through specific receptors, thereby entering cells and replicating within them. Viral infections stimulate interferon-mediated innate immune responses. Recent studies suggest that viral infections may also induce type 2 immune responses and stimulate the aberrant production of cytokines that can result in loss of barrier function, which is a hallmark in CRS. The main purpose of this review will be to highlight common viruses and their associated binding receptors and highlight pathophysiologic mechanisms associated with alterations in mucociliary clearance, epithelial barrier function, and dysfunctional immune responses that might lead to a further understanding of the pathogenesis of CRS. |
DOI | 10.1016/j.jaci.2023.07.018 |
Alternate Journal | J Allergy Clin Immunol |
PubMed ID | 37574080 |
PubMed Central ID | PMC10592176 |
Grant List | R01 AI146131 / AI / NIAID NIH HHS / United States |
Viral infections and chronic rhinosinusitis.
Faculty Reference:
Eugene H. Chang, MD